Search by Drug Name or NDC

    NDC 25021-0661-10 midazolam 5 mg/mL Details

    midazolam 5 mg/mL

    midazolam is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is MIDAZOLAM HYDROCHLORIDE.

    Product Information

    NDC 25021-0661
    Product ID 25021-661_002ea282-09ba-4d79-8bd1-94c9859f442b
    Associated GPIs
    GCN Sequence Number 003780
    GCN Sequence Number Description midazolam HCl VIAL 5 MG/ML INJECTION
    HIC3 H22
    HIC3 Description GENERAL ANESTHETICS,INJECTABLE-BENZODIAZEPINE TYPE
    GCN 40850
    HICL Sequence Number 001619
    HICL Sequence Number Description MIDAZOLAM HCL
    Brand/Generic Generic
    Proprietary Name midazolam
    Proprietary Name Suffix n/a
    Non-Proprietary Name midazolam hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name MIDAZOLAM HYDROCHLORIDE
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA090850
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0661-10 (25021066110)

    NDC Package Code 25021-661-10
    Billing NDC 25021066110
    Package 10 VIAL in 1 CARTON (25021-661-10) / 10 mL in 1 VIAL
    Marketing Start Date 2012-03-19
    NDC Exclude Flag N
    Pricing Information N/A